105
Participants
Start Date
July 28, 2021
Primary Completion Date
December 31, 2021
Study Completion Date
June 10, 2022
CPL-01
Subjects will receive a single dose
Naropin 150 MG Per 20 ML Injection
Subjects will receive a single dose
Placebo
Subjects will receive a single dose
Shoals Medical Trials, Inc, Sheffield
First Surgical Hospital, Bellaire
Jean Brown Research, Salt Lake City
Arizona Research Center, Phoenix
Anaheim Clinical Trials, Anaheim
Lead Sponsor
Cali Pharmaceuticals LLC
INDUSTRY